Amalgamated Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Hold |
10,911
| – | – | ﹤0.01% | 1398 |
|
|
2025
Q1 | $362K | Sell |
10,911
-168
| -2% | -$5.57K | ﹤0.01% | 1361 |
|
|
2024
Q4 | $381K | Buy |
11,079
+2,074
| +23% | +$71.3K | ﹤0.01% | 1392 |
|
|
2024
Q3 | $360K | Sell |
9,005
-720
| -7% | -$28.8K | ﹤0.01% | 1421 |
|
|
2024
Q2 | $293K | Sell |
9,725
-719
| -7% | -$21.7K | ﹤0.01% | 1478 |
|
|
2024
Q1 | $351K | Sell |
10,444
-3,559
| -25% | -$120K | ﹤0.01% | 1438 |
|
|
2023
Q4 | $452K | Sell |
14,003
-1,239
| -8% | -$40K | ﹤0.01% | 1481 |
|
|
2023
Q3 | $499K | Buy |
15,242
+1,395
| +10% | +$45.7K | ﹤0.01% | 1411 |
|
|
2023
Q2 | $487K | Buy |
13,847
+856
| +7% | +$30.1K | ﹤0.01% | 1447 |
|
|
2023
Q1 | $424K | Sell |
12,991
-851
| -6% | -$27.8K | ﹤0.01% | 1493 |
|
|
2022
Q4 | $763K | Buy |
13,842
+30
| +0.2% | +$1.65K | 0.01% | 1258 |
|
|
2022
Q3 | $612K | Buy |
13,812
+2,234
| +19% | +$99K | 0.01% | 1336 |
|
|
2022
Q2 | $565K | Buy |
11,578
+428
| +4% | +$20.9K | 0.01% | 1409 |
|
|
2022
Q1 | $542K | Sell |
11,150
-472
| -4% | -$22.9K | ﹤0.01% | 1509 |
|
|
2021
Q4 | $496K | Buy |
+11,622
| New | +$496K | ﹤0.01% | 1577 |
|